Table 2 Treatment and prognosis of neuroendocrine carcinoma
From: Neuroendocrine carcinoma of gallbladder: a case series and literature review
No. | Surgery | Margin | Chemotherapy | Radiotherapy | Follow-up (months) | Prognosis |
|---|---|---|---|---|---|---|
1 | Radical dissection of gallbladder and liver quadrate lobe | R1 | No | No | 15 | Recurrence |
2 | Radical dissection of gallbladder and liver quadrate lobe | R2 | 4 cycles of EP + 2 cycles of gemcitabine | No | 25 | No recurrence |
3 | Radical dissection of gallbladder | R3 | NA | NA | 5 | Death |
4 | Radical dissection of gallbladder | R2 | 1 cycle of irinotecan and cisplatin | No | 12 | Recurrence |
5 | Gallbladder mass biopsy | NA | No | No | 3 | Death |
6 | Laparoscopic cholecystectomy | NA | NA | NA | 29 | No Recurrence |
7 | Laparoscopic cholecystectomy | NA | NA | NA | 29 | No Recurrence |
8 | Laparoscopic cholecystectomy | NA | NA | NA | 45 | No Recurrence |